Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Rowe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|August 22, 2012
Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefitI A Rowe, D D Houlihan, D J Mutimer
Alimentary Pharmacology & Therapeutics|March 16, 2013
Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitisR Parker, M J Armstrong, C Corbett, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2025
Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK CityR Parker, A Taylor, R Dukes, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD programM J Armstrong, D D Houlihan, I A Rowe, et al.
Postgraduate Medical Journal|August 9, 2013
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practiceM J Armstrong, C Corbett, J Hodson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|August 22, 2012
Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefitI A Rowe, D D Houlihan, D J Mutimer
Alimentary Pharmacology & Therapeutics|March 16, 2013
Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitisR Parker, M J Armstrong, C Corbett, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2025
Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK CityR Parker, A Taylor, R Dukes, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2012
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD programM J Armstrong, D D Houlihan, I A Rowe, et al.
Postgraduate Medical Journal|August 9, 2013
Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practiceM J Armstrong, C Corbett, J Hodson, et al.
Pageof 1